GenSight Biologics S.A. (EPA:SIGHT)
France · Delayed Price · Currency is EUR 0.1558
+0.0068 (4.56%)
Jul 25, 2025, 4:39 PM CET
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €22.99 million as of July 25, 2025. Its market cap has decreased by -26.79% in one year.
Market Cap
22.99M
Enterprise Value
39.64M
Revenue
2.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.16
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 22.99M, a decrease of -90.88%. That is a compound annual growth rate of -23.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 113.54B |
| Sanofi | 103.12B |
| Sartorius Stedim Biotech | 16.82B |
| bioMérieux | 14.39B |
| Eurofins Scientific SE | 11.26B |
| Ipsen | 9.00B |
| ABIVAX Société Anonyme | 3.45B |
| Virbac | 3.03B |